A prospective study of camrelizumab monotherapy following definitive concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell cancer
第一作者机构：[1]Radiotherapy Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
推荐引用方式(GB/T 7714)：
Wang J.,Cheng Y.,Wu Y.,et al.A prospective study of camrelizumab monotherapy following definitive concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell cancer[J].ANNALS OF ONCOLOGY.2021,32:S838-S838.doi:10.1016/j.annonc.2021.08.1362.
APA：
Wang, J.,Cheng, Y.,Wu, Y.,Cao, F.,Liu, Q.&Gao, G..(2021).A prospective study of camrelizumab monotherapy following definitive concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell cancer.ANNALS OF ONCOLOGY,32,
MLA：
Wang, J.,et al."A prospective study of camrelizumab monotherapy following definitive concurrent chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell cancer".ANNALS OF ONCOLOGY 32.(2021):S838-S838
医学